With their proliferation, differentiation into specific cell types, and secretion properties, mesenchymal stromal/stem cells (MSC) are very interesting tools to be used in regenerative medicine. Bone marrow (BM) was the first MSC source characterized. In the frame of autologous MSC therapy, it is important to detect donor’s parameters affecting MSC potency. Age of the donors appears as one parameter that could greatly affect MSC properties. Moreover, in vitro cell expansion is needed to obtain the number of cells necessary for clinical developments. It will lead to in vitro cell aging that could modify cell properties. This review recapitulates several studies evaluating the effect of in vitro and in vivo MSC aging on cell properties.
StoltzJ.-F.de IslaN.LiY.P.BensoussanD.ZhangL.HuselsteinC.ChenY.DecotV.MagdalouJ.LiN.ReppelL. and HeY., Stem cells and regenerative medicine: Myth or reality of the 21th century, Stem Cells Int2015 (2015), 734731.
2.
BakerN.BoyetteL.B. and TuanR.S., Characterization of bone marrow-derived mesenchymal stem cells in aging, Stem Cells Bone70 (2015), 37–47.
3.
BaxterM.A.WynnR.F.JowittS.N.WraithJ.E.FairbairnL.J. and BellantuonoI., Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion, Stem Cells Dayt Ohio22 (2004), 675–682.
4.
FanM.ChenW.LiuW.DuG.-Q.JiangS.-L.TianW.-C.SunL.LiR.-K. and TianH., The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction, Rejuvenation Res13 (2010), 429–438.
5.
MareschiK.FerreroI.RustichelliD.AscheroS.GammaitoniL.AgliettaM.MadonE. and FagioliF., Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow, J. Cell. Biochem.97 (2006), 744–754. doi:10.1002/jcb.20681.
6.
MendesS.C.TibbeJ.M.VeenhofM.BakkerK.BothS.PlatenburgP.P.OnerF.C.de BruijnJ.D. and van BlitterswijkC.A., Bone tissue-engineered implants using human bone marrow stromal cells: Effect of culture conditions and donor age, Tissue Eng8 (2002), 911–920.
7.
DexheimerV.MuellerS.BraatzF. and RichterW., Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age, PloS One6 (2011), e22980.
8.
StolzingA.JonesE.McGonagleD. and ScuttA., Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies, Mech. Ageing Dev.129 (2008), 163–173. doi:10.1016/j.mad.2007.12.002.
9.
ZhouS.GreenbergerJ.S.EpperlyM.W.GoffJ.P.AdlerC.LeBoffM.S. and GlowackiJ., Age-related intrinsic changes in human bone marrow-derived mesenchymal stem cells and their differentiation to osteoblasts, Aging Cell7 (2008), 335–343.
10.
LiY.CharifN.MainardD.BensoussanD.StoltzJ.-F. and de IslaN., Donor’s age dependent proliferation decrease of human bone marrow mesenchymal stem cells is linked to diminished clonogenicity, Biomed. Mater. Eng.24 (2014), 47–52.
11.
SiegelG.KlubaT.Hermanutz-KleinU.BiebackK.NorthoffH. and SchäferR., Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells, BMC Med.11 (2013), 146. doi:10.1186/1741-7015-11-146.
12.
MartinC.OlmosÉ.CollignonM.-L.de IslaN.BlanchardF.ChevalotI.MarcA. and GuedonE., Revisiting MSC expansion from critical quality attributes to critical culture process parameters, Process Biochem.
13.
WagnerW.BorkS.LepperdingerG.JoussenS.MaN.StrunkD. and KochC., How to track cellular aging of mesenchymal stromal cells?, Aging2 (2010), 224. doi:10.18632/aging.100136.
14.
WagnerW.HornP.CastoldiM.DiehlmannA.BorkS.SaffrichR.BenesV.BlakeJ.PfisterS.EcksteinV. and HoA.D., Replicative senescence of mesenchymal stem cells: A continuous and organized process, PloS One3 (2008), e2213.
15.
DigirolamoC.M.StokesD.ColterD.PhinneyD.G.ClassR. and ProckopD.J., Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate, Br J Haematol107 (1999), 275–281. doi:10.1046/j.1365-2141.1999.01715.x.
16.
SekiyaI.LarsonB.L.SmithJ.R.PochampallyR.CuiJ.-G. and ProckopD.J., Expansion of human adult stem cells from bone marrow stroma: Conditions that maximize the yields of early progenitors and evaluate their quality, Stem Cells Dayt Ohio20 (2002), 530–541.
17.
ChenH.H.DecotV.OuyangJ.P.StoltzJ.F.BensoussanD. and de IslaN.G., In vitro initial expansion of mesenchymal stem cells is influenced by the culture parameters used in the isolation process, Biomed. Mater. Eng.19 (2009), 301–309.
18.
BascianoL.NemosC.FoliguetB.de IslaN.de CarvalhoM.TranN. and DalloulA., Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status, BMC Cell Biol.12 (2011), 12. doi:10.1186/1471-2121-12-12.
19.
SetheS.ScuttA. and StolzingA., Aging of mesenchymal stem cells, Ageing Res. Rev.5 (2006), 91–116.
20.
RussellK.C.PhinneyD.G.LaceyM.R.BarrilleauxB.L.MeyertholenK.E. and O’ConnorK.C., In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment, Stem Cells28 (2010), 788–798. doi:10.1002/stem.312.
21.
OreffoR.O.BordS. and TriffittJ.T., Skeletal progenitor cells and ageing human populations, Clin. Sci. Lond. Engl. 197994 (1998), 549–555. doi:10.1042/cs0940549.
22.
OreffoR.O.BennettA.CarrA.J. and TriffittJ.T., Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors, Scand. J. Rheumatol.27 (1998), 415–424. doi:10.1080/030097498442235.
23.
DominiciM.Le BlancK.MuellerI.Slaper-CortenbachI.MariniF.KrauseD.DeansR.KeatingA.ProckopD. and HorwitzE., Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement, Cytotherapy8 (2006), 315–317. doi:10.1080/14653240600855905.
24.
MaijenburgM.W.KleijerM.VermeulK.MulE.P.J.van AlphenF.P.J.van der SchootC.E. and VoermansC., The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging, Haematologica97 (2012), 179–183. doi:10.3324/haematol.2011.047753.
25.
WagnerW.BorkS.HornP.KrunicD.WalendaT.DiehlmannA.BenesV.BlakeJ.HuberF.-X.EcksteinV.BoukampP. and HoA.D., Aging and replicative senescence have related effects on human stem and progenitor cells, PloS One4 (2009), e5846.
26.
EvansC.E.GalaskoC.S. and WardC., Effect of donor age on the growth in vitro of cells obtained from human trabecular bone, J. Orthop. Res. Off. Publ. Orthop. Res. Soc.8 (1990), 234–237. doi:10.1002/jor.1100080212.
27.
ZaimM.KaramanS.CetinG. and IsikS., Donor age and long-term culture affect differentiation and proliferation of human bone marrow mesenchymal stem cells, Ann. Hematol.91 (2012), 1175–1186. doi:10.1007/s00277-012-1438-x.
28.
HarmanD., Aging: A theory based on free radical and radiation chemistry, J. Gerontol.11 (1956), 298–300. doi:10.1093/geronj/11.3.298.
29.
BenameurL.CharifN.LiY.StoltzJ.-F. and de IslaN., Toward an understanding of mechanism of aging-induced oxidative stress in human mesenchymal stem cells, Biomed. Mater. Eng.25 (2015), 41–46.
30.
GuZ.CaoX.JiangJ.LiL.DaZ.LiuH. and ChengC., Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients, Cell. Signal.24 (2012), 2307–2314. doi:10.1016/j.cellsig.2012.07.012.
31.
ChengH.QiuL.MaJ.ZhangH.ChengM.LiW.ZhaoX. and LiuK., Replicative senescence of human bone marrow and umbilical cord derived mesenchymal stem cells and their differentiation to adipocytes and osteoblasts, Mol. Biol. Rep.38 (2011), 5161–5168. doi:10.1007/s11033-010-0665-2.
32.
BrandlA.MeyerM.BechmannV.NerlichM. and AngeleP., Oxidative stress induces senescence in human mesenchymal stem cells, Exp. Cell Res.317 (2011), 1541–1547. doi:10.1016/j.yexcr.2011.02.015.
33.
Valle-PrietoA. and CongetP.A., Human mesenchymal stem cells efficiently manage oxidative stress, Stem Cells Dev.19 (2010), 1885–1893. doi:10.1089/scd.2010.0093.
34.
SongH.ChaM.-J.SongB.-W.KimI.-K.ChangW.LimS.ChoiE.J.HamO.LeeS.-Y.ChungN.JangY. and HwangK.-C., Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex, Stem Cells Dayt Ohio28 (2010), 555–563.
35.
HeoJ.-Y.JingK.SongK.-S.SeoK.-S.ParkJ.-H.KimJ.-S.JungY.-J.HurG.-M.JoD.-Y.KweonG.-R.YoonW.-H.LimK.HwangB.-D.JeonB.H. and ParkJ.-I., Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells, Stem Cells Dayt Ohio27 (2009), 1455–1462.
ArmstrongL.LakoM.LincolnJ.CairnsP.M. and HoleN., mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells, Mech. Dev.97 (2000), 109–116. doi:10.1016/S0925-4773(00)00423-8.
38.
SimonsenJ.L.RosadaC.SerakinciN.JustesenJ.StenderupK.RattanS.I.S.JensenT.G. and KassemM., Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells, Nat. Biotechnol.20 (2002), 592–596. doi:10.1038/nbt0602-592.
39.
StenderupK.JustesenJ.ClausenC. and KassemM., Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells, Bone33 (2003), 919–926. doi:10.1016/j.bone.2003.07.005.
40.
ReppelL.MargossianT.YaghiL.MoreauP.MercierN.LegerL.HupontS.StoltzJ.-F.BensoussanD. and HuselsteinC., Hypoxic culture conditions for mesenchymal stromal/stem cells from Wharton’s jelly: A critical parameter to consider in a therapeutic context, Curr. Stem Cell Res. Ther.9 (2014), 306–318.
41.
ZimmermannS.VossM.KaiserS.KappU.WallerC.F. and MartensU.M., Lack of telomerase activity in human mesenchymal stem cells, Leukemia17 (2003), 1146–1149. doi:10.1038/sj.leu.2402962.
